Articles for category "In the Media"

10 January 2020 ·  In the Media

Recommended Reviews in Plant Biotechnology and Molecular Pharming

Some of the reviews in the February 2020 issue of the journal Current Opinion in Biotechnology focus on the production of high-value medicinal products in plants via molecular pharming, like monoclonal antibodies to treat Ebola, as well as on other products produced in plants for therapies, vaccines or cancer biologics. Moreover, Mary Williams recommends her readers to study this special Plant Biotechology issue in the knowledge hub Plantae since it not only covers reviews that introduce strategies to increase efficiency or versatility of plants as pharmaceutical producers but also provide insight into the value / optimization of specific plants like green algae or mosses. The issue rounds off by informing about progress and policies concerning gene-edited plants. Ralf Reski edited this special Plant Biotechnology issue of the journal Current Opinion in Biotechnology together with his colleagues Gary Foster and Ed Rybicki.

Source: Plantae

Follow link
11 April 2019 ·  In the Media

Regeneration of moss cells depends on their position

ScienceDaily reported about our development of a new single-cell RNA sequencing technology, single cell-digital gene expression that is able to measure the transcriptome while preserving the positional information of the cell in the tissue. Together with our colleagues from Japan we validated this technology in the moss Physcomitrella patens by measuring how the location of a cell in a leaf influences its properties for cellular reprogramming. First author Minoru Kubo has invented the described method of microcapillary manipulation in the ReskiLab before he went back to Japan. We published these results open access in the journal Nucleic Acids Research (DOI:

Source: ScienceDaily

Follow link
22 January 2019 ·  In the Media

Peat moss devices monitor polystyrene plastic pollution

A recent article that appeared in Botany One highlights that our Italian colleagues in the EU FP7-funded MOSSclone project have shown that the invented device containing peat moss Sphagnum palustre is also capable to monitor plastic pollution - besides air pollution for which we invented this tool in the first place. In the Italian study, polystyrene nanoparticles entrapped in the devices increased with increasing exposure time, which means that this is a suitable measuring method. The used devitalized S. palustre material was even better at retaining nanoparticles than living material. Moreover, the production of this measuring material is sustainable, since we produced the mosses from clones in bioreactors.

Source: Botany One

Follow link
22 October 2018 ·  Angewandte Forschung · In the Media

Unser MOOSzucht-Projekt im TV

Der Kameramann zoomt ganz nah ran an die Pflanzen, die im Moosbioreaktor optimale Bedingungen zum Wachsen finden. Foto: Ralf Reski

Die ARD-Sendung "W wie Wissen" berichtet anschaulich, wie Moos-Biotechnologie, Paludikultur und Landwirtschaft zusammenwirken können, um Moore zu retten und das Klima zu schützen. Im Film wird u.a. das MOOSzucht-Projekt des ReskiLabs vorgestellt (ungefähr ab Minute 25). Wer den Film "Der Kampf um das Moor" vergangenen Samstag nicht live ansehen konnte, kann den Film nun in der Mediathek anschauen.

Quelle: ARD Mediathek

Follow link
07 October 2018 ·  In the Media

Moss-derived active ingredient in anti-aging product

Under the title "MossCellTech n.1, un’innovazione che rivoluzionerà il mercato cosmetico dell’anti-aging" an article appeared in the personal care division of AVG's website, in which they introduce the first moss-derived active, natural ingredient for the cosmetic market, developed by our co-operation partner Mibelle Biochemistry. The award-winning MossCellTec No.1 is derived from bioreactor cultures of Physcomitrella patens.


Follow link
25 May 2018 ·  In the Media

The Plant Cell in a nutshell: RecQ protein function in moss uncovered

A blog post summarizes our findings that the protein RecQ6 in Physcomitrella patens enhances homologous recombination and gene targeting. In her article "RecQ Proteins: Masters of Genome Surveillance" on the Plantae Blog author Nancy Eckardt introduces our paper Wiedemann et al. about the RecQ family that functions in development, DNA repair, and gene targeting. The comparison of the proteins in the model plants Physcomitrella patens and Arabidopsis thaliana by Ralf Reski’s team might explain why the moss is much more efficient in homologous recombination and thus gene targeting than the other plant. Since RecQ6 enhances gene targeting it may hold a key to enable modifications in crop plants in the future.

Source: Plantae Blog 

Follow link
23 May 2018 ·  In the Media

A potential biopharmaceutical: mossFH

The report Atypical HUS Therapeutic Drug Pipeline 2018 mentions mossFH in its drug discovery trends as “innovative and promising”. The glyco-protein mossFH developed by ReskiLab & Greenovation is produced in the moss Physcomitrella patens on pure mineral media in bioreactors. It may serve as an enzyme-replacement therapy (ERT) in the future in patients suffering from Atypical Hemolytic Uremic Syndrome (aHUS), an extremely rare, life-threatening, progressive disease.

Source: aHUSAllicanceAction

Follow link
14 May 2018 ·  In the Media

Moss-derived cosmetic ingredients

More than forty species of mosses are in use in traditional medicine and cultures of the moss Physcomitrella patens are now used to sustainably produce cosmetic ingredients as the website Premium Beauty News reports. The Swiss-based company Mibelle Biochemistry capitalizes on a technology developed by us to sustainably cultivate moss protonema cells under sterile conditions at large scale. The biotechnologically produced botanical ingredient named MossCellTec No.1 is fixed on a powder based on isomalt and received two Gold awards at the cosmetic fare in-cosmetics Global. According to Premium Beauty News, the sustainably produced ingredients for this anti-aging concept of Mibelle seem to match current demands for natural ingredients. Biotechnology may become one of the main sources of innovation for sustainable natural ingredients in the cosmetics industry, according to a market research study.

Source: Premium Beauty News

Follow link
02 May 2018 ·  In the Media

Argumente vs. Ideologie

Seit Wochen wird auf Twitter über Pflanzen-Gentechnik diskutiert. Wie Tobias Maier (Twitter: @WeiterGen), promovierter Biologe und wissenschaftlicher Leiter am Nationalen Institut für Wissenschaftskommunikation, in seinem Blog WeiterGen berichtet, stellen sich auch Pflanzenwissenschaftler der Diskussion mit verschiedenen Politikerinnen und Politikern der GRÜNEN, die teils unter dem Hashtag #Gentechnikwende geführt werden, teils ohne. Unter der Überschrift "Frontberichte vom Kampf gegen Ideologie" macht Maier auf die Diskussion aufmerksam und zitiert die beiden Pflanzenwissenschaftler Professor Detlef Weigel (@PlantEvolution) vom Max-Planck-Institut für Entwicklungsbiologie in Tübingen und Professor Ralf Reski (@ReskiLab) von der Uni Freiburg. Leider finde der Austausch über Pflanzen-Gentechnik aber nicht auf Augenhöhe statt, beklagt Maier, dessen Blog Teil der ScienceBlogs Community des Konradin-Verlags ist. Denn die Fragen und Argumente der Wissenschaftler blieben unbeantwortet oder werden lediglich mit Scheinargumenten erwidert. Es sei aber längst klar, dass die GRÜNEN wider besseren Wissens bewusst Fakten ignorieren, um ihre Lobby- und Agendapolitik zu betreiben, schreibt Maier.

Quelle: WeiterGen bei ScienceBlogs

Follow link
24 April 2018 ·  In the Media

Resilient skin from moss-based ingredient

The Personal Care Magazine reported about Prof. Ralf Reski’s presentation on the unique abilities of mosses. As he pointed out, millions of years ago mosses first were able to acquire nutrients from rocks, protect themselves from UV radiation and withstand freezing temperatures. Reski was invited to talk about mosses’ abilities at the Nemo Science Museum in Amsterdam prior to the Fair in-cosmetics Global. He and the representatives of the Swiss company Mibelle BioChemistry, Dr Fred Zuelli and Dr Franziska Wandrey, introduced the new active ingredient MossCellTec No. 1 for skin cosmetics that is produced biotechnologically and sustainably from Physcomitrella patens protonemata. The new ingredient improves nuclear pore health and thus hydration, barrier and homogeneity of the human skin.

Source: Personal Care Magazine

Follow link
20 April 2018 ·  In the Media

Gold for moss ingredient

Ceremony of the Innovation Award. Photo: in-cosmetics Global

The active ingredient MossCellTech No. 1 received the "Innovation Award" in gold at the fair in-cosmetics Global in Amsterdam on April 17. As the online portal Cosmetics Business reports, it is awarded because it is the first cosmetics active ingredient derived from a moss. ReskiLab has collaborated with the Swiss company Mibelle BioChemistry to produce the ingredients via biotechnology in a sustainable way from juvenile moss protonemata of Physcomitrella patens. MossCellTech No. 1 helps the skin to maintain cell nucleus health and enables it to adapt to environmental changes. In a short video in YouTube [0:54 min] the managing director of Mibelle BioChemistry, Fred Zuelli, tells more about receiving the award.

Source: Cosmetics Business

Follow link
23 March 2018 ·  In the Media

Moss-made biopharmaceuticals

The patient organization aHUS Alliance interviewed Ralf Reski about research results and the production of human complement Factor H (FH) in moss. The atypical Hemolytic Uremic Syndrome (aHUS) is an extremely rare, life-threatening, progressive disease. So far, patients suffering from this illness cannot be cured but only be treated to alleviate symptoms. Since some patients are deficient in the complement system’s regulatory FH protein, FH produced in moss may serve as an enzyme-replacement therapy (ERT) in the future. Preclinical tests with bioassays and FH-deficient mice show promising results. They may even work better than the human protein because moss-FH is very homogenously decorated with specific sugar residues.

Source: aHUS Alliance

Follow link
14 February 2018 ·  In the Media

First moss-made drug passes phase I with promising results

The first drug produced in the moss Physcomitrella patens has passed clinical trial phase I with excellent results. In this study the drug moss-aGAL to combat the rare and incurable Fabry disease was tolerated well by the patients and had a high efficacy. The glyco-protein aGalactosidase A (moss-aGal) was tested in six patients as enzyme replacement therapy (ERT). The drug made in moss bioreactors can be produced ten times cheaper compared to existing animal expression hosts. Moreover, moss-aGAL was taken up faster into the endothelian kidney cells thanks to a different glycosylation of the enzyme (revealed in animal models) and also delivered higher yields, making it a real bio-better. In an interview with the German biotech journal Transkript the CEO of Greenovation Biotech GmbH, Dr. Thomas Frischmuth, talks about these encouraging results and looks ahead into the plans for phases II and III. Under the headline “moss cells pass suitability tests” Frischmuth also names candidates, which could be the next moss-made drugs to come, like human Factor H, which once could be used to combat glomerulopathies of the kidney (C3G), atypical hemolytic uremic syndrome (aHUS), or age-related macular degeneration (AMD) in the eye. Professor Ralf Reski and Professor Gunter Neuhaus founded the privately owned biotech company Greenovation in 1999.

Source: Transkript

Follow link
27 October 2017 ·  In the Media

Green Chemicals from Moss

How the new EU project MossTech with involvement of professor Ralf Reski will promote the environmentally friendly production of specialty chemicals from genetically modified moss, is described in the online portal Bioeconomy (“Bioökonomie”). Reski and his team will advance existing technologies like the genome editing tool CRISPR-Cas9 and apply it to mosses that have not been analysed so far. He and his team had found out earlier that the moss Physcomitrella patens contains roughly 10,000 more genes than the human genome; many of them encode the synthesis of highly complex chemical molecules. The project to sustainably produce specialty chemicals, which is coordinated by the Technical University of Denmark in Copenhagen, will receive €1.6 million from the EU (Horizon 2020 programme) and about €500,000 will go to the University of Freiburg.

Source: Bioö

Follow link
26 May 2017 ·  In the Media

From Moss to Humans

How plant biotechnologist professor Ralf Reski conducts basic research at the University of Freiburg is portrayed at the Health Industry BW website (BW = Baden-Württemberg, a state in Germany). Some of the research results and his ideas shall also become concrete products for treating rare diseases. This is why he established Greenovation Biotech GmbH some years ago, a company, which produces novel drugs in mosses. The company’s first moss-produced drug candidate – Moss-aGal – a recombinant form of human alpha-galactosidase, is now being tested in a phase I clinical trial. In the article, Reski also shares how he handles publications and patents.

see Health Industry BW

Follow link
21 April 2017 ·  In the Media

Green Triggers

Many million years ago, mosses spread over the earth, increased the amount of oxygen in the atmosphere, and provided a basis for animal and human life. Photo: Daniel Lang, Plant Biotechnology, Freiburg

How plant scientist Ralf Reski pursues molecular archeology using the moss Physcomitrella patens is described in the magazine Research & Discover of the University of Freiburg. Around 450 million years ago, plants rapidly spread on the very first continent, which increased the oxygen and reduced the carbon dioxide contents of the atmosphere, creating conditions that made human and animal life on land possible. The article introduces three scientific studies published in the renowned journals Nature Plants and Nature Communications. They explain the "inventions" of a protective outer layer and the simple stomata as well as the molecular mechanism responsible for the alternation of generations between sexual and asexual reproduction, which is typical for all land plants.

see: Research & Discover at University of Freiburg

Follow link
14 March 2017 ·  In the Media

Plant Cuticles

Under the title "Plant Cuticles Of Moss Actually Protects The Plant From Water Loss" The Science Times describes the biological pathway that is responsible for the production the waxy substance that covers the surface of the moss Physcomitrella and protects it from water loss. This was a prerequisite in the evolutionary transition in plants from fresh water to land. The Science Times also introduces the methods used by the scientists from the University of Freiburg, Germany, and the Centre National de la Recherche Scientifique (CNRS) Institute of Plant Molecular Biology (IBMP) in Strasbourg, France, to reveal the new findings.

see The Science Times 

Follow link
16 December 2016 ·  In the Media

First Preclinical Data Show Full Bioactivity of Moss-FH

Scientists of Greenovation Biotech GmbH and the German Universities of Freiburg and Jena have published data in the Journal of the American Society of Nephrology showing full bioactivity of the human complement factor H produced in the moss Physcomitrella patens (moss-FH). The results demonstrate its ability to control complement activation in serum derived from aHUS patients as well as in a C3G mouse model. The results were obtained in part by Dr. Juliana Parsons, Lennard Bohlender, Dr. Sebastian Hoernstein, PD Dr. Eva Decker, and Prof. Dr. Ralf Reski. The privately owned company Greenovation was founded by Prof. Dr. Gunter Neuhaus and Reski and develops next-generation therapeutics using its proprietary BryoTechnology platform. The company aims to optimize the production of highly-efficient glycoproteins for proprietary and customer use.

whole media release at Greenovation

Follow link
15 August 2016 ·  In the Media

Gene for reproduction without sex discovered in a moss

The Natural History Magazine reports about our discovery of a gene that triggers reproduction without sex in the moss Physcomitrella patensRalf Reski and Nelly Horst at the University of Freiburg together with biologist Nir Ohad at Tel Aviv University and other scientists have published the results about the BELL family of genes in P. patens in a paper in the science journal Nature Plants.

read more in the Natural History Magazine

Follow link
14 August 2016 ·  In the Media · Lehre

TREASURE WATER: Neue Lehrpläne zum Wassermanagement

Hörfunk-Interview mit Ralf Reski zum EU-Projekt TREASURE-WATER, einem internationalen Konsortium mit 14 Partnern aus sechs Ländern, das neue Lehrpläne für die nachhaltige, grenzüberschreitende und friedliche Nutzung von Wasser entwickeln will.

Interview von SWR4 Radio Südbaden (mp3-Datei)

27 July 2016 ·  In the Media

Musgo para detectar la contaminación atmosférica

The Spanish Website analaqua reported about our research project.

read Spanish article

Follow link
In the Media

BioValley-Newsletter no 1

Joint research project: BASF committed to the BioValley!
In the BioValley, BASF will be working with Senior Lecturer Dr. Ralf Reski at Freiburg University.

read whole Newsletter (pdf)

13 July 2016 ·  In the Media

Les origines inattendues de la photosynthèse

The journal The Conversation reports about our latest finding on the origin of photosynthesis.  

read more in The Conversation 

Follow link
In the Media

BioValley-Newsletter no 3

The third Newsletter reports about the Center for Applied Biosciences (ZAB) at Freiburg University and the prject "Functional genomics in plants through highly efficient homologous recombination" by Prof. Reski.

read whole Newsletter (pdf)

18 February 2016 ·  In the Media

Trigger for asexual reproduction

Under the title "Scientists discover trigger for asexual plant reproduction" the Israelian nonprofit online news magazine Israel21c reported about our findings.

read whole English article

Follow link
19 January 2016 ·  In the Media

Asexual: Offspring Without Fertilization In Plants

A team has discovered a gene trigger in the moss Physcomitrella patens which leads to offspring without fertilization. This probabely holds the key to answer fundamental questions in biology.

Read whole story in the online platform Science 2.0

Follow link
19 January 2016 ·  In the Media

Discovery of a gene trigger for asexual reproduction

A German-Israeli team led by the biologists Professor Ralf Reski from Freiburg and Professor Nir Ohad from Tel-Aviv has discovered a gene trigger in the moss Physcomitrella patens which leads to offspring without fertilization.

Read whole article in the Heritage Daily an online science, research and publishing news service

Follow link
01 January 2016 ·  In the Media

Moss-made pharmaceuticals

Moss-made pharmaceuticals are highlighted in the 2015 Plant Science Round Up, composed by The Global Plant Council: see highlight in May.

Read whole Round up by the Global Plant Council

Follow link
30 December 2015 ·  In the Media

A cool development

Who Tried to Save the World in 2015? A list in GreenTech this year names Moss-made pharmaceuticals "One of the coolest developments in GreenTech 2015"

Read article in the European Biotech News Website

Follow link
07 December 2015 ·  Applied research · In the Media

Peat moss for measuring air pollution

Continuous monitoring of environmental air quality has been mandatory in the EU since 1996. However, state-of-the-art technical measurement systems are expensive and lack mobility. A European consortium led by biologist Prof. Dr. Ralf Reski has developed a new system that uses peat moss in so-called ”MOSSpheres” for monitoring air pollution. The project MOSSclone started in April 2012 and funding ended in March 2015.

read all at Bioeconomy BW website

Follow link
06 November 2015 ·  Applied research · In the Media

First moss-made drug

The world’s first moss-produced drug candidate has the go-ahead to enter clinical trials

read whole story in the Journal Nature Biotechnology

23 September 2015 ·  Applied research · In the Media

Drug from Moss

Greenovation is allowed to start clinical trial for moss-aGal

read whole story at

Follow link
16 September 2015 ·  Applied research · In the Media

Phase I clinical trial for moss-aGal

Greenovation to start Phase I clinical trial for moss-aGal, a recombinant form of human alpha galactosidase.

read whole story in European Pharmaceutical Review

Follow link
14 September 2015 ·  Applied research · In the Media

Start Phase I Clinical Trial For Moss-aGal

Greenovation Receives BfArM Approval To Start Phase I Clinical Trial For Moss-aGal, The World´S First Moss-Produced Drug Candidate

read whole story in the Clinical Leader

Follow link
27 August 2015 ·  Applied research · In the Media

Start of early clinical trials with moss-aGal allowed

Fabry Enzyme Replacement Therapy (ERT) Based On Mannose-Mediated Cellular Uptake Shows Encouraging Preclinical Results That Allow Start Of Early Clinical Trials

read whole report in the Clinical Leader

Follow link
10 July 2015 ·  Applied research · In the Media

Greenovation: Using Moss as a Drug Production Factory

Factor H, a key component of the immune system that is missing in patients suffering from atypical hemolytic uremic syndrome (aHUS), was effectively produced in the moss Physcomitrella patens. In collaboration with the University of Freiburg, Greenovation now aims to humanize the protein to suit it for clinical use.

read whole article on the website

Follow link
10 July 2015 ·  In the Media

The “Voinnet Case”: Incorrect Measures for Incorrect Figures?

The magazine Lab Times online reports about the formal investigations by the ETH Zürich and the French CNRS which identified numerous incorrect figures in about twenty publications by plant biologist Olivier Voinnet. Nevertheless, he is to keep his laboratory and professorship at the ETH. Hard to understand, as many colleagues express their astonishment. One of them being cited is Ralf Reski.

read whole story and Reski's quote on Lab Times online

Follow link
06 July 2015 ·  Applied research · In the Media

Using mosses to produce medicines

Human disease can be treated with substances from traditional medicinal plants or with molecular pharming products. Molecular pharming uses genetic engineering techniques to insert genes into plants or animals that would otherwise not express these genes. These transgenics can then be used to produce therapeutic proteins such as antibodies. Dr. Eva Decker from the University of Freiburg and her team have now successfully produced a key protein of the human immune system in the moss Physcomitrella patens. Recombinant factor H might be used at some stage in the future for the therapy of atypical haemolytic uremic syndrome, a rare, life-threatening disease that affects kidney function.

read whole article at Healthcare Indurstry BW

Follow link
29 June 2015 ·  In the Media

Offener Brief zu Glyphosat in Muttermilch

Ein offener Brief bemängelt die als Studie bezeichnete Untersuchung zu Glyphosat in Muttermilch, die wissenschaftlichen Standards nicht standhält.

ganzer Beitrag auf dem Blog Stallbesuch von Thomas Wengenroth

Follow link
15 October 2014 ·  Basic research · In the Media

Tough as Old Moss

Credit resilience to environmental change for its longevity. The American Scholar reports about the Publication in the Journal New Phytologist in which members of the ReskiLab show that orphan genes in Physcomitrella patens may be related to cold acclimation.

read more in the The American Scholar

Follow link
16 September 2014 ·  In the Media

Mosses survive climate catastrophes

The website Heritage Daily describes why mosses survived climate changes that destroyed more complex organisms such like dinosaurs.

read whole article at Heritage Daily

Follow link
15 September 2014 ·  In the Media

Mosses survive climate catastrophes

The web-based science, research and technology website Phys.Org reports about our research.

read more at Phys.Org

Follow link
15 September 2014 ·  In the Media

Moss plants brought back to life ...

... after having been frozen in Antarctic ice for 1,500 years. The Magazine Science Daily introduces the reasarch results on orphan genes in mosses.

read whole article at Science Daily

Follow link
25 April 2014 ·  In the Media

Glyphosate toxicity study in 'pay for play journal'

Glyphosate toxicity study published a team, led by Gilles-Eric Séralini, in 'pay for play journal' is based on flawed experimental design

read report in Genetic Literacy Project

Follow link
04 March 2014 ·  In the Media

Séralini's Latest

Séralini's Latest: Will History Repeat Itself? Asks the Blog GMO Pundit a.k.a. David Tribe

Follow link
10 February 2014 ·  In the Media

Pesticide Study Sparks Backlash

The journal Science reports on Ralf Reskis reaction to the latest paper of G.E. Seralini in its rubric Science Insider.

read whole story at Science Insider

Follow link
31 January 2014 ·  In the Media

Seralini has done it again!

The blog Raving Scientist reports on G.E. Seralini's latest paper, including Ralf Reski's reasons to resign as editor of BioMed International.

read more at ravingscientist

Follow link
09 August 2013 ·  In the Media

Moss Sequencing “Ennobles” Flagship Genome

The Physcomitrella Genome is expected to provide help with global climate change, reports the US Department of Energy Joint Genome Institute (DOE JGI) about our international team of scientists that has annotated all 32,275 genes of the moss Physcomitrella patens.

read more at DOE JGI blog rubric "Science Highlights"

Follow link
08 August 2013 ·  In the Media

"We Welcome Our Moss Overlords"

The blog The Sensuous Curmudgeon reports about the German, Belgian and Japanese scientists, coordinated by Professor Ralf Reski from the University of Freiburg, Germany, that described the 32,275 protein-encoding genes from the moss Physcomitrella patens.

read more at The Sensuous Curmudgeon

Follow link
05 August 2013 ·  In the Media

Production of therapeutic proteins in moss

The greenovation Biotech GmbH, which has its headquarters in Heilbronn and a branch in Freiburg, uses its proprietary bryotechnology to produce and commercialise antibodies, enzymes and coagulation factors “made from moss”, reports the website Healthcare industry BW.

read more at Healthcare industry BW

Follow link
05 August 2013 ·  In the Media

Simple Body Plan, A Lot Of Genetic Complexity

The magazine Science 2.0 introduces our study about the moss genome.

read more on Science 2.0

Follow link
05 August 2013 ·  In the Media

Moss Beats Human

A simple moss plant outperforms us by gene number reports the magazine Science Daily.

read more at Science Daily

Follow link
05 July 2013 ·  In the Media

Starke Achse zwischen Freiburg und Strasbourg

Forschungskollegs fördern gemeinsame Forschergruppen. Das berichtet das Portal Kooperation International des BMBF.

weiterlesen bei Kooperation International des BMBF

Follow link
24 June 2013 ·  In the Media

Das neue Wundermittel der Medizin

Über Zucker auf Rezept berichtet das P.M. Magazin in seiner Ausgabe 05/2013.

Follow link
15 June 2013 ·  In the Media

Gesundes Polster

Das Magazin Apotheken Umschau berichtet über Moose: seit Jahrtausenden vom Menschen als Naturmittel geschätzt aber heutzutage wird sein Potential kaum noch ausgeschöpft. Dabei kann die Arbeitsgruppe um Ralf Reski mit Moosen medizinische Substanzen herstellen.

weiterlesen Apotheken Umschau

03 June 2013 ·  In the Media

Plants that track air pollution

Biotechnology to fight air pollution: A video at euronews reports about the European research collaboration MOSSclone, introduces the project and the people involved. Members of the ReskiLab, Dr. Eva Decker and Professor Ralf Reski, explain, why mosses are suitable to collect pollutants.

watch video at euronews

Follow link
24 May 2013 ·  In the Media

EU TEMPUS meeting QualFEEM

Members of the "Qualifications Framework for Ecology and Environmental Management" (QualFEEM) project met in Tyumen, Russia.

A Russian video is available on YouTube

Follow link
11 April 2013 ·  In the Media

Ralf Reski auf Platz 25 der meistzitierten Köpfe in der Pflanzenforschung

Die Zeitschrift Laborjournal hat in der aktuellen Ausgabe die Veröffentlichungen der Pflanzenwissenschaftler der Jahre 2007-2010 ausgewertet und nennt die meistzitierten Köpfe und Artikel. Im Forscher-Ranking liegt der Freiburger Biotechnologe Ralf Reski auf Platz 25 des gesamten deutschen Sprachraums.

weiterlesen beim Laborjournal

Follow link
11 April 2013 ·  In the Media

Publikationsanalyse Pflanzenforschung (2007-2010)

Im Einleitungstext zum Publikations-Ranking nennt die Zeitschrift Laborjournal das "Haustier" der Freiburger Biotechnologen um Ralf Reski. Das Team erforscht das Moos Physcomitrella patens, die Eroberung des Landes durch Pflanzen und untersucht Gene für Trockenstresstoleranz.

weiterlesen beim Laborjournal

Follow link
24 September 2012 ·  In the Media

Radiointerview zur Ratten-Studie von Prof. Seralini

Prof. Ralf Reski legt im uniradio Freiburg dar, warum die Ratten-Experimente von Prof. Seralini und die dazu veröffentlichte Studie keinen wissenschaftlichen Ansprüchen genügt. Das betrifft die Auswahl der Versuchstiere, das Studiendesign und die statistische Auswertung.

Radiointerview hören (mp3, 10:22 Min)

15 August 2012 ·  In the Media

Greenovation melkt das Blasenmützenmoos

Die Badische Zeitung berichtet über das aus der Uni ausgegründete Unternehmen, das aus Moosen Proteine gewinnt, die auch im Kampf gegen Krebs eingesetzt werden können.

weiterlesen bei der Badischen Zeitung

Follow link
13 August 2012 ·  In the Media

Global denken, lokal handeln (Bayer CropScience)

Bayer CropScience Deutschland über die Freiburger Tagung, die Prof. Ralf Reski und Prof. Heinz Rennenberg organiseren.

Follow link
03 August 2012 ·  In the Media

"Besuch aus dem All"

Über den Besuch des Astronauten Hans Wilhelm Schlegel beim derzeitigen Plant Biology Congress berichtet die Badische Zeitung. Dazu kamen zwischen dem 29. Juli und 3. August rund 900 Pflanzenforscher aus aller Welt auf Einladung ihrer Freiburger Kollegen Heinz Rennenberg und Ralf Reski diese Woche in Freiburg zusammen.

weiterlesen bei der Badischen Zeitung

Follow link
05 June 2012 ·  In the Media

Engineered moss produces human hormone

The website Healthcare industry reports about our production of Erythropoietin (EPO) in the moss Physcomitrella patens and the paper from the team around  Dr. Eva Decker and Ralf Reski in the Plant Biotechnology Journal.

read whole article at Healthcare industry BW

Follow link
05 June 2012 ·  In the Media

Gentech-Moos produziert EPO

Forscher erzeugen einen Bioreaktor für das menschliche Hormon aus einer Pflanze, berichtet das Wissenschaftsmagazin Scinexx.

weiterlesen bei Scinexx

Follow link
04 June 2012 ·  In the Media

EPO aus dem Moos-Bioreaktor

Freiburger Forschern ist es gelungen, das Eiweißhormon EPO im Moosbioreaktor zu produzieren berichtet das Portal Biotechnologie.

weiterlesen bei

Follow link
03 April 2012 ·  In the Media

Future forests, moss analyst

The online platform Compute Scottland reported about the MOSSclone project and the five countries involved.

read whole article in Compute Scottland

Follow link
09 December 2011 ·  In the Media

Moss Well Invested

read more at ScienceDaily

Follow link
22 August 2011 ·  In the Media

Can the stress tolerance of moss be transferred to maize and other plants?

In an interview with the portal Bioeconomy BW, Ralf Reski explained what agricultural crops can learn from their ancestral relatives.

Follow link
28 March 2011 ·  In the Media

In German Elections, Major Research Region Goes Green

read more in Science

Follow link
14 December 2010 ·  Grundlagenforschung · In the Media

No Phenylketonuria in Certain Plants

The magazine Science Daily reports that the PAH gene found to be present in plants as well as animals.

read more at Science Daily

Follow link
08 August 2010 ·  In the Media

Human protein produced in a moss bioreactor

The website BioPro reports about our findings.

read more at BioPro

Follow link
28 July 2010 ·  In the Media

Medicine from moss to produce human protein


Follow link
23 July 2010 ·  In the Media

Medicine from moss

Bioreactor technique may offer hope to people with age-related blindness reports the magazine ScienceDaily.

read more at ScienceDaily

Follow link
22 July 2010 ·  In the Media

Medicine from moss

The website myScience reports about our findings.

read more at myScience

Follow link
10 June 2010 ·  In the Media

Moss Can Be Used As 'Surrogate Mother' To Human Genes

The website inventorspot reports about our findings.

read more at inventorspot

Follow link
21 May 2010 ·  In the Media

A small moss turns professional

The website Healthcare industry BW reports about the “International Moss Stock Centre” (IMSC) and how moss research will profit from its establishment.

read more at Healthcare industry BW

Follow link
10 January 2010 ·  In the Media

Discovery: microRNAs can directly turn off genes

 TS-Si reports

Follow link
27 November 2009 ·  In the Media

Physcomitrella not a model for monophyly

In her Blog Jessica M. Budke reports about our paper in the journal Evolution "The Speciation history of the Physcomitrium-Physcomitrella species complex" and the model organism Physcomitrella patens.

read more in the Blog

Follow link
30 September 2009 ·  In the Media

Moss may hold stem cell programming clues

The website United Press International, USA, (UPI) reports about our findings.

read more at UPI

Follow link
29 September 2009 ·  In the Media

Telltale Moss

read more at the blog magazine scienceblog

Follow link
03 July 2009 ·  In the Media

Green Stem Cells in a Moss

The website Healthcare industry BW reports about our discovery and what makes the difference between cells in a moss.

read more at Healthcare industry BW

Follow link
23 May 2009 ·  In the Media

Moss That Swings Both (All?) Ways

read Blog by Jennifer Frazer

Follow link
30 October 2008 ·  In the Media

"Moss Plants and More"

Jessica M. Budke reports in her Blog "Moss Plants and More" about moss research.

read more

Follow link
07 May 2008 ·  In the Media

Genedata and FRISYS Turn Over New Leaf in Systems Biology Collaboration

more at Genedata

Follow link
14 December 2007 ·  In the Media

Moss genome sequenced

The sequenced moss genome of the model organism Physcomitrella patens shows how aquatic plants adapted to dry land - key to development of drought-tolerant energy crops, cellulosic biofuels. Biopact reports

read more at Biopact

Follow link
08 November 2006 ·  In the Media

Moss Systems Biology with group from Shanghai

the website BioPro reports

Follow link
04 October 2006 ·  In the Media

Joint Project on Molecular Farming in Moss Bioreactor Granted

website BioPro reports

Follow link
13 October 2004 ·  In the Media

Moss genome to be sequenced

read more at BioValley Journal

28 January 1999 ·  In the Media

Spotlight on Biovalley

Naturejobs reports about the two fastest growing biotechnology regions, one of them is in the Southwest of Germany, near us. 

read whole article at

Follow link